Dr. Gregory L. Kearns, Pharm.D., Ph.D., Joins Madeira Therapeutics Board of Advisors

LEAWOOD, Kan.--(BUSINESS WIRE)--Madeira Therapeutics, a company specializing in pediatric pharmaceuticals, is pleased to announce that Dr. Gregory L. Kearns, Pharm.D., Ph.D., Chairman of the Department of Medical Research and Director of the Pediatric Pharmacology Research Unit at Children’s Mercy Hospitals and Clinics in Kansas City, Missouri, has elected to serve as a member of the Company’s Board of Advisors. Dr. Kearns brings an extensive amount of experience in pediatric research and drug development to Madeira’s Advisory Board.

MORE ON THIS TOPIC